


Belite Bio Email Formats
Biotechnology Research • San Diego, California, United States • 21-50 Employees
Belite Bio Email Formats
Belite Bio uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@belitebio.com), used 64.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@belitebio.com | 64.3% |
{first name}{last name} | johndoe@belitebio.com | 35.7% |
Key Contacts at Belite Bio
John Longo
Member Board Of Directors
Paul Leonard
Senior Director Cmc
Ita Lu
Independent Director
Lisa Liang
Senior Director Of Clinical Operations
Gary Y. H. Teng
Associate Director
Company overview
| Headquarters | 5820 Oberlin Drive, Suite 101, San Diego, California 92121, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Diabetes, Drug Development, Nash, Nafld, Dry Age-Related Macular Degeneration, Rbp4, Stargardt Disease |
| Founded | 2018 |
| Employees | 21-50 |
| Socials |
About Belite Bio
Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Belite Bio has 10 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore Belite Bio's funding history, including investment rounds, total capital raised, and key backers.
Belite Bio Tech Stack
Discover the technologies and tools that power Belite Bio's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
JavaScript libraries
Mobile frameworks
JavaScript libraries
CDN
JavaScript libraries
Programming languages
Blogs
Page builders
PaaS
Frequently asked questions
4.8
40,000 users



